135 related articles for article (PubMed ID: 2322789)
1. Faecal occult blood screening for colorectal neoplasia: a randomized trial of three days or six days of tests.
Thomas WM; Pye G; Hardcastle JD; Mangham CM
Br J Surg; 1990 Mar; 77(3):277-9. PubMed ID: 2322789
[TBL] [Abstract][Full Text] [Related]
2. Population screening for colorectal cancer: comparison between guaiac and immunological faecal occult blood tests.
Robinson MH; Marks CG; Farrands PA; Thomas WM; Hardcastle JD
Br J Surg; 1994 Mar; 81(3):448-51. PubMed ID: 8173928
[TBL] [Abstract][Full Text] [Related]
3. Screening for colorectal cancer with an immunological faecal occult blood test: 2-year follow-up.
Robinson MH; Marks CG; Farrands PA; Bostock K; Hardcastle JD
Br J Surg; 1996 Apr; 83(4):500-1. PubMed ID: 8665240
[TBL] [Abstract][Full Text] [Related]
4. Self-reported dark red bleeding as a marker comparable with occult blood testing in screening for large bowel neoplasms.
Silman AJ; Mitchell P; Nicholls RJ; Macrae FA; Leicester RJ; Bartram CI; Simmons MJ; Campbell PD; Hearn CE; Constable PJ
Br J Surg; 1983 Dec; 70(12):721-4. PubMed ID: 6605779
[TBL] [Abstract][Full Text] [Related]
5. Faecal occult blood testing and colonoscopy in the surveillance of subjects at high risk of colorectal neoplasia.
Robinson MH; Kronborg O; Williams CB; Bostock K; Rooney PS; Hunt LM; Hardcastle JD
Br J Surg; 1995 Mar; 82(3):318-20. PubMed ID: 7795994
[TBL] [Abstract][Full Text] [Related]
6. Role of dietary restriction in Haemoccult screening for colorectal cancer.
Thomas WM; Pye G; Hardcastle JD; Chamberlain J; Charnley RM
Br J Surg; 1989 Sep; 76(9):976-8. PubMed ID: 2679967
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Coloscreen Self-Test and Haemoccult faecal occult blood tests in the detection of colorectal cancer in symptomatic patients.
Pye G; Jackson J; Thomas WM; Hardcastle JD
Br J Surg; 1990 Jun; 77(6):630-1. PubMed ID: 2200550
[TBL] [Abstract][Full Text] [Related]
8. A comparison of an immunological faecal occult blood test Fecatwin sensitive/FECA EIA with Haemoccult in population screening for colorectal cancer.
Armitage N; Hardcastle JD; Amar SS; Balfour TW; Haynes J; James PD
Br J Cancer; 1985 Jun; 51(6):799-804. PubMed ID: 4005139
[TBL] [Abstract][Full Text] [Related]
9. Haemoccult screening for colorectal cancer: the effect of dietary restriction on compliance.
Robinson MH; Pye G; Thomas WM; Hardcastle JD; Mangham CM
Eur J Surg Oncol; 1994 Oct; 20(5):545-8. PubMed ID: 7926056
[TBL] [Abstract][Full Text] [Related]
10. Patient compliance with colorectal cancer screening in general practice.
Mant D; Fuller A; Northover J; Astrop P; Chivers A; Crockett A; Clements S; Lawrence M
Br J Gen Pract; 1992 Jan; 42(354):18-20. PubMed ID: 1586526
[TBL] [Abstract][Full Text] [Related]
11. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.
Hardcastle JD; Chamberlain JO; Robinson MH; Moss SM; Amar SS; Balfour TW; James PD; Mangham CM
Lancet; 1996 Nov; 348(9040):1472-7. PubMed ID: 8942775
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of occult blood tests over a six-day period.
Farrands PA; Hardcastle JD
Clin Oncol; 1983 Sep; 9(3):217-25. PubMed ID: 6616996
[TBL] [Abstract][Full Text] [Related]
13. Is an immunological faecal occult blood test better than Haemoccult? A cost-benefit study.
Robinson MH; Marks CG; Farrands PA; Whynes DK; Bostock K; Hardcastle JD
Eur J Surg Oncol; 1995 Jun; 21(3):261-4. PubMed ID: 7781793
[TBL] [Abstract][Full Text] [Related]
14. Haemoccult test properties according to type and number of positive slides in mass screening for colorectal cancer.
Launoy G; Herbert C; Reaud JM; Thezee Y; Tichet J; Maurel J; Ollivier V; Pegulu L; Caces E; Valla A
Br J Cancer; 1995 Oct; 72(4):1043-6. PubMed ID: 7547220
[TBL] [Abstract][Full Text] [Related]
15. Chemical and immunological testing for faecel occult blood: a comparison of two tests in symptomatic patients.
Thomas WM; Hardcastle JD; Jackson J; Pye G
Br J Cancer; 1992 Apr; 65(4):618-20. PubMed ID: 1562472
[TBL] [Abstract][Full Text] [Related]
16. Screening for colorectal carcinoma: an analysis of the sensitivity of haemoccult.
Thomas WM; Pye G; Hardcastle JD; Walker AR
Br J Surg; 1992 Aug; 79(8):833-5. PubMed ID: 1393487
[TBL] [Abstract][Full Text] [Related]
17. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test.
Levi Z; Hazazi R; Rozen P; Vilkin A; Waked A; Niv Y
Aliment Pharmacol Ther; 2006 May; 23(9):1359-64. PubMed ID: 16629942
[TBL] [Abstract][Full Text] [Related]
18. Faecal occult blood screening for colorectal neoplasia in a targeted high-risk population.
Caffarey SM; Broughton CI; Marks CG
Br J Surg; 1993 Nov; 80(11):1399-400. PubMed ID: 8252347
[TBL] [Abstract][Full Text] [Related]
19. An industry based approach to colorectal cancer screening in an asymptomatic population.
Hart AR; Glover N; Howick-Baker J; Mayberry JF
Postgrad Med J; 2003 Nov; 79(937):646-9. PubMed ID: 14654576
[TBL] [Abstract][Full Text] [Related]
20. A case-control study to evaluate efficacy of screening for faecal occult blood.
Lazovich D; Weiss NS; Stevens NG; White E; McKnight B; Wagner EH
J Med Screen; 1995; 2(2):84-9. PubMed ID: 7497161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
